With more than 15 million patients in Europe and in the United States, Heart failure is associated with tremendously high healthcare costs and remains the largest unmet clinical need in the cardiovascular world.
Enopace Biomedical Ltd. is developing an innovative device to treat heart failure patients. Enopace's technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload.
HIL Applied Medical is developing a new class of ultra-compact, high-performance proton therapy systems. We apply a patented approach to particle acceleration and beam delivery, combining nano-technology with ultra-high-intensity lasers and advanced magnetics. These technological breakthroughs enable meaningful reduction in the size, complexity and cost of proton therapy systems, without compromising clinical utility.
Thus HIL aims to enable, for the first time, a single-room add-on proton therapy solution that is truly cost-effective.
MobileODT is reimagining medical visualization technology to enhance women’s health. Combining advanced imaging, data and software applications, MobileODT is saving lives by enabling early cancer detection. The flagship EVA System mobile colposcope is in use in 27 countries and in 50 USA health systems. It allows providers to visualize the cervix, document exams, add annotations and filters directly to cervical images, and collaborate with peers remotely. The EVA System has application for clinical colposcopy and forensic imaging. MobileODT is constantly evolving, adapting it’s products to a variety of clinical settings and is currently exploring the integration of AI for cancer detection.
Nano Retina is an innovative company that took on the ambitious goal of restoring vision to blind people using advanced nanotechnology.
Nano Retina was founded in 2009 by two visionary industry experts; Yossi Gross, a serial entrepreneur, inventor and co-founder of Rainbow Medical, and Jim von Ehr, a leader within the field of nanotechnology and founder and CEO of Zyvex Labs.
Based on sound scientific knowledge and through rigorous research processes the team at Nano Retina is developing a device that will enable blind people due to retinal degenerative disease gain functional vision.
While a relatively young company, Nano Retina has managed to make giant technological leaps with the cumulative experience of its team members. Made up of engineers, physicists, ophthalmologists, low vision specialists and regulatory experts the Nano Retina team has a joint experience of over 200 years.
Nano Retina has offices in Herzliya, Israel and it partners with distinguished research centers and technology manufacturers throughout the world.
An Israeli biotech company with a drug targeting diseases of the Central Nervous System. The company’s lead drug candidate is being studied in a phase 3 clinical trial for stroke of the optic nerve and a phase 2 clinical study in Canada for mild/moderate Alzheimers.
TechsoMed is an Israel-based Biotech company engaged in the development of BioTrace™ - world’s first real-time monitoring and control systems for ablation procedure. Our breakthrough technology brings disruptive improvement to thermal ablation through real-time AI and image analysis, and it can do all that by interfacing with standard ultrasound device. The safety, efficacy and significant cost reduction we offer to physicians, make our product a must-have system for any ablation procedures worldwide.